COVID-19 increases mortality in hemodialysis patients: exploring links with inflammation and telomere attrition.

Publication date: Aug 27, 2024

An increased risk of mortality and hospitalization was consistently demonstrated in hemodialysis (HD) patients affected by pandemic coronavirus infection (COVID-19). In this study, we analyzed parameters that may impact mortality in COVID-19 HD patients, including neutrophil-to-lymphocyte ratio (NLR), lactate dehydrogenase (LDH), C-reactive protein (CRP), COVID-19 disease status and telomere length in peripheral blood cells (TL). A total of 130 chronic hemodialysis patients were enrolled and followed up for 18 months. Patients were categorized into groups based on their COVID-19 disease history and subsequent data about their survival status at the end of the study. Routine laboratory parameters were assessed using standard automated methods and TL was determined using the modified Cawthon method. Survival predictors were analyzed using Kaplan-Meier analysis. Deceased patients (30%) were older with higher body mass index (BMI), higher levels of LDH, NLR index, CRP and lower TL and lymphocytes count compared to survivors. Kaplan-Meier survival analysis showed six parameters were significant mortality predictors in the following order of significance: COVID-19 history, 2-years cardiovascular mortality risk score, NLR, TL, CRP, LDH. Using binary logistic regression analysis Summary risk score, a combination of these six parameters revealed as the best predictor of patient’s survival in this group of parameters (log rank 25. 4, p 

Concepts Keywords
Coronavirus Aged
Covid C-Reactive Protein
Hemodialysis C-Reactive Protein
Increased COVID-19
Pandemic COVID-19
Female
Hemodialysis
Humans
Inflammation
Inflammation
Kaplan-Meier Estimate
Kidney Failure, Chronic
L-Lactate Dehydrogenase
L-Lactate Dehydrogenase
Lymphocytes
Male
Middle Aged
Mortality rate
Neutrophils
Renal Dialysis
SARS-CoV-2
Telomere
Telomere

Semantics

Type Source Name
disease MESH COVID-19
disease MESH inflammation
disease MESH coronavirus infection
disease IDO blood
disease IDO history
drug DRUGBANK Protein C
disease MESH Kidney Failure Chronic

Original Article

(Visited 3 times, 1 visits today)